SGLT2 inhibitors linked to lower risk of kidney stones in patients with type 2 diabetes

Rates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidney stones, but some forms of treatment for this condition may also have the benefit of lowering risk of kidney stones.

Asthma Attacks Decreased Among Black Patients During the Pandemic

Despite Black patients having the highest prevalence of asthma prior to the COVID-19 pandemic, decreasing trends in asthma attacks were observed for this population during

December 19, 2023

First AKT Inhibitor Approved for Advanced Breast Cancer

The FDA approved the first-in-class AKT inhibitor capivasertib (Truqap), in combination with fulvestrant, for locally advanced/metastatic hormone receptor (HR)-positive/HER2-negative breast cancer and at least one

November 18, 2023

Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics – Biotech Investments

Heidelberg Pharma AG / Key word(s): Miscellaneous Heidelberg Pharma Sells Minority Shareholding in Emergence Therapeutics 29-Jun-2023 / 09:45 CET/CEST Disclosure of an inside information acc.

June 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.